Jianwen C. Qin
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Efficacy and challenges of immunotherapy in advanced EGFR-mutant NSCLC: a case report.
Journal: Frontiers in oncology
Published: April 03, 2026
International Consensus on Severe Lung Cancer-The Second Edition.
Journal: Translational lung cancer research
Published: March 21, 2026
Fatal AA-like bone marrow failure and invasive pulmonary aspergillosis after long-term pembrolizumab in squamous NSCLC: a case report.
Journal: Frontiers in immunology
Published: January 31, 2026
Development and Multi-center Validation of a Breathomics-Based Triage Tool for Lung Cancer: A Prospective Study of 5,214 Participants.
Journal: Chest
Published: January 09, 2026
Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.
Journal: Cancer communications (London, England)
Published: November 29, 2025
Expert consensus on cancer treatment-related lung injury.
Journal: Journal of thoracic disease
Published: February 12, 2025
Efficient harvesting of triplet excitons via multiple fast TTA up-conversion and high-lying reverse intersystem crossing channels for efficient blue fluorescent organic light-emitting diodes.
Journal: Chemical science
Published: September 14, 2024
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study.
Journal: The Lancet. Respiratory medicine
Published: August 11, 2024
Pulmonary pathological changes in the patient undergoing lung transplantation after chronic graft-versus-host disease complicated by pulmonary infection post-hematopoietic stem cell transplantation: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: July 02, 2024
ctDNA SNORD3F Hypermethylation is a Prognostic Indicator in EGFR-TKI-Treated Advanced Non-Small Cell Lung Cancer.
Journal: Cancer management and research
Published: April 19, 2024
Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer.
Journal: Frontiers in oncology
Published: February 11, 2024
Last Updated: 09/26/2026